Provided by Tiger Trade Technology Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

78.09
-0.9400-1.19%
Post-market: 78.090.00000.00%19:30 EDT
Volume:710.97K
Turnover:55.55M
Market Cap:3.43B
PE:-72.14
High:79.10
Open:78.67
Low:77.33
Close:79.03
52wk High:91.53
52wk Low:53.85
Shares:43.88M
Float Shares:35.64M
Volume Ratio:1.21
T/O Rate:1.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0824
EPS(LYR):-1.5900
ROE:-13.68%
ROA:-5.48%
PB:9.88
PE(LYR):-49.11

Loading ...

May 03, 2022

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 02, 2022

Major Issues Report

8-K - Current report
May 02, 2022

Major Issues Report

8-K - Current report
Mar 14, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 14, 2022

Major Issues Report

8-K - Current report
Mar 14, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2022

Major Issues Report

8-K - Current report
Jan 28, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 04, 2022

Major Issues Report

8-K - Current report
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2021

Major Issues Report

8-K - Current report
Nov 03, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 01, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Major Issues Report

8-K - Current report